Clinical Trial Update: Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus donor lymphocyte infusion to prevent second relapse after allogeneic stem cell transplant in relapsed acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Donor Lymphocyte Infusion

Snippet

Sponsor: Peking University People's Hospital | Conditions: Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 | Status: UNKNOWN